Efficacy of muscle relaxant for supraglottic device insertion

Efficacy of muscle relaxant for supraglottic device insertion - Significance of muscle relaxant for supraglottic device insertion

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017488

Enrollment

Registered

2015-05-11

Start date

2015-05-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient who undergo general anesthesia with supraglottic device

Interventions

To administer muscle relaxant on supraglottic device insertion Not to administer muscle relaxant on supraglottic device insertion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient who undergo general anesthesia with SGD

Exclusion criteria

Exclusion criteria: Patient who are contraindicated for SGD insertion.

Design outcomes

Primary

Measure	Time frame
Insertion Success rate Sealing Pressure	—

Secondary

Measure	Time frame
Postoperative pharyngeal pain, hoarseness Subjective difficulty of insertion	—

Countries

Japan

Contacts

Public ContactKomasawa Nobuyasu

Osaka Medical College Anesthesiology

ane078@poh.osaka-med.ac.jp0726-84-6361

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026